Wunderlich Securities has named Gregory Simpson a senior vice president in equity research.
Simpson, who will cover the medical-devices and technology sector, previously was co-director of healthcare and the principal senior medical device analyst for Stifel Nicolaus. The appointment reflects an expansion of Wunderlich Securities' technology group, a spokeswoman for the Memphis, Tenn.-based brokerage firm said in an e-mail.
Simpson was the lead medical-device analyst for A.G. Edwards & Sons before joining Stifel Nicolaus. He holds a master's in business administration from the University of Missouri.